IL17A and myeloid sarcoma: IL-17 gene expression is significantly higher in mononuclear cells derived from the blood and cerebrospinal fluid (CSF) of MS patients when compared to healthy controls (HCs), and the numbers of IL-17-expressing blood mononuclear cells are higher during MS exacerbations in comparison to clinically silent periods (7).